Total Liabilities: The total value of all possible claims against the corporation.
Axsome Therapeutics, Inc. (AXSM) had Total Liabilities of $659.02M for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
$191.20M |
|
$-64.54M |
|
$14.72M |
|
$176.48M |
|
$254.56M |
|
$-63.36M |
|
$-1.19M |
|
$-64.54M |
|
$-64.54M |
|
$-64.54M |
|
$-64.54M |
|
$-64.54M |
|
$-64.54M |
|
$-63.36M |
|
$-60.83M |
|
51.20M |
|
51.20M |
|
$-1.26 |
|
$-1.26 |
|
| Balance Sheet Financials | |
$611.21M |
|
$0.57M |
|
$102.40M |
|
$713.61M |
|
$439.21M |
|
$123.69M |
|
$219.81M |
|
|
Total Liabilities |
$659.02M |
$54.59M |
|
$3.60M |
|
$54.59M |
|
51.42M |
|
| Cash Flow Statement Financials | |
$-20.70M |
|
$-0.12M |
|
$2.99M |
|
$322.93M |
|
$305.11M |
|
$-17.83M |
|
$23.44M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.39 |
|
-- |
|
-- |
|
0.69 |
|
3.55 |
|
92.30% |
|
-33.14% |
|
-33.14% |
|
-- |
|
-33.76% |
|
-33.76% |
|
$-20.82M |
|
-- |
|
-- |
|
-- |
|
0.27 |
|
0.47 |
|
0.76 |
|
118.18 |
|
-118.24% |
|
-1793.84% |
|
-9.04% |
|
-36.20% |
|
$1.06 |
|
$-0.41 |
|
$-0.40 |
|